Using laser technology to detect early signs of vision loss from radiation treatment
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
This study is looking at how a special imaging technique can help spot early signs of eye damage in patients with uveal melanoma who have had radiation therapy, so we can find ways to prevent vision loss before it happens.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10839445 on NIH RePORTER |
What this research studies
This research investigates how laser speckle flowgraphy can be used to identify early signs of microvascular damage in the eyes of patients who have undergone radiation therapy for uveal melanoma. By measuring blood flow and the eye's response to light, the study aims to detect endothelial dysfunction before significant vision loss occurs. The approach involves noninvasive imaging techniques applied to both human subjects and animal models to understand the underlying mechanisms of radiation-induced damage. The ultimate goal is to develop strategies for preventing or treating vision loss in these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received brachytherapy for uveal melanoma and are at risk of developing vision loss.
Not a fit: Patients who have not undergone radiation therapy for eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier interventions that preserve vision in patients treated for uveal melanoma.
How similar studies have performed: While the concept of using imaging to detect microvascular changes is established, this specific application of laser speckle flowgraphy in the context of radiation-induced vision loss is relatively novel.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Grumbach, Isabella Maria — University of Iowa
- Study coordinator: Grumbach, Isabella Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.